• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter: programmed cell death protein-1-targeted immunotherapy for advanced hepatocellular carcinoma.

作者信息

Liu Xu, Jia Rong-Rong, Zhang Chun-Yan

机构信息

Experimental Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.

Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.

出版信息

Aliment Pharmacol Ther. 2019 Aug;50(3):340-341. doi: 10.1111/apt.15336.

DOI:10.1111/apt.15336
PMID:31313360
Abstract
摘要

相似文献

1
Letter: programmed cell death protein-1-targeted immunotherapy for advanced hepatocellular carcinoma.信函：程序性细胞死亡蛋白-1靶向免疫疗法治疗晚期肝细胞癌
Aliment Pharmacol Ther. 2019 Aug;50(3):340-341. doi: 10.1111/apt.15336.
2
Letter: programmed cell death protein-1-targeted immunotherapy for advanced hepatocellular carcinoma-authors' reply.信函：程序性细胞死亡蛋白-1靶向免疫疗法治疗晚期肝细胞癌——作者回复
Aliment Pharmacol Ther. 2019 Aug;50(3):341-342. doi: 10.1111/apt.15368.
3
Letter: programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort-more questions than answers.信函：晚期肝细胞癌中程序性细胞死亡蛋白1（PD-1）靶向免疫疗法：来自一项国际多中心真实世界队列的疗效和安全性数据——问题多于答案
Aliment Pharmacol Ther. 2019 Jul;50(2):230. doi: 10.1111/apt.15322.
4
Letter: programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort-more questions than answers. Authors' reply.信函：晚期肝细胞癌中程序性细胞死亡蛋白-1（PD-1）靶向免疫疗法：来自国际多中心真实世界队列的疗效和安全性数据——问题多于答案。作者回复
Aliment Pharmacol Ther. 2019 Jul;50(2):231-232. doi: 10.1111/apt.15334.
5
Programmed cell death protein-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectives.肝细胞癌中的程序性细胞死亡蛋白 1（PD-1）/程序性死亡配体 1（PD-L1）轴：预后和治疗展望。
Clin Transl Oncol. 2019 Jun;21(6):702-712. doi: 10.1007/s12094-018-1975-4. Epub 2018 Nov 1.
6
Y-90 Radioembolization Combined with a PD-1 Inhibitor for Advanced Hepatocellular Carcinoma.钇-90放射性栓塞联合PD-1抑制剂治疗晚期肝细胞癌
Cardiovasc Intervent Radiol. 2018 Nov;41(11):1799-1802. doi: 10.1007/s00270-018-1993-1. Epub 2018 May 29.
7
It takes two to tango: breakthrough advanced hepatocellular carcinoma treatment that combines anti-angiogenesis and immune checkpoint blockade.探戈需两人共舞：联合抗血管生成和免疫检查点阻断的晚期肝细胞癌突破性治疗
J Formos Med Assoc. 2021 Jan;120(1 Pt 1):1-4. doi: 10.1016/j.jfma.2020.07.009. Epub 2020 Jul 11.
8
Recent developments with immunotherapy for hepatocellular carcinoma.肝细胞癌免疫治疗的最新进展。
Expert Opin Biol Ther. 2018 Aug;18(8):905-910. doi: 10.1080/14712598.2018.1499722. Epub 2018 Jul 20.
9
Programmed cell death protein-1 inhibitors for immunotherapy of advanced nonmelanoma skin cancer: showing early promise.程序性细胞死亡蛋白-1抑制剂用于晚期非黑素瘤皮肤癌的免疫治疗：显示出早期前景。
Br J Dermatol. 2016 Dec;175(6):1150-1151. doi: 10.1111/bjd.14905.
10
Combination of tumor-associated regulatory T cell deletion and PD-1/PD-L1 blockade: A promising immunotherapy for hepatocellular carcinoma?肿瘤相关调节性T细胞缺失与PD-1/PD-L1阻断联合应用：肝细胞癌一种有前景的免疫疗法？
Hepatobiliary Pancreat Dis Int. 2018 Apr;17(2):93-94. doi: 10.1016/j.hbpd.2018.03.001. Epub 2018 Mar 8.